Abstract
Epigenetic parameters linked to E-cadherin gene were investigated in 5 human colorectal cancer cell lines. Treatment with trichostatin A led to enhanced acetylation of histone H3-K9 with concurrent induction of E-cadherin mRNA in 3 E-cadherin low/negative cell lines that are not DNA methylated. Co-treatment with 5-aza-2′-deoxycytidine and trichostatin A resulted in additive/synergic induction of E-cadherin mRNA in all 5 cell lines with concomitant enhancement of histone H3-K9 acetylation in 4 E-cadherin low/negative cell lines. Our results suggest that histone H3-K9 deacetylation appears to play a crucial role in transcriptional repression of E-cadherin in colorectal cancers.
ABBREVIATIONS | ||
E-cad | = | E-cadherin |
CDH1 | = | E-cadherin gene |
CRC | = | colorectal cancer |
H3-K9 acetylation | = | acetylation of histone H3 (Lys 9) |
H3-K9 methylation | = | methylation of histone H3 (Lys 9) |
PMR | = | percentage of methylated reference |
DAC | = | 5-aza-2′-deoxycytidine |
TSA | = | trichostatin A |
ABBREVIATIONS | ||
E-cad | = | E-cadherin |
CDH1 | = | E-cadherin gene |
CRC | = | colorectal cancer |
H3-K9 acetylation | = | acetylation of histone H3 (Lys 9) |
H3-K9 methylation | = | methylation of histone H3 (Lys 9) |
PMR | = | percentage of methylated reference |
DAC | = | 5-aza-2′-deoxycytidine |
TSA | = | trichostatin A |